Cargando…

Size Matters: The Influence of Patient Size on Antibiotics Exposure Profiles in Critically Ill Patients on Continuous Renal Replacement Therapy

(1) Purpose of this study: To determine whether patient weight influences the probability of target attainment (PTA) over 72 h of initial therapy with beta-lactam (cefepime, ceftazidime, piperacillin/tazobactam) and carbapenem (imipenem, ertapenem, meropenem) antibiotics in the critical care setting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Soo-Min, Shaw, Alex R., Mueller, Bruce A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615189/ https://www.ncbi.nlm.nih.gov/pubmed/34827327 http://dx.doi.org/10.3390/antibiotics10111390

Ejemplares similares

Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2020)

Renal replacement therapy for critically ill patients: an intermittent continuity
por: Ricci, Zaccaria, et al.
Publicado: (2014)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

Continuous Renal Replacement Therapy in Critically Ill Children
por: Demirkol, Demet
Publicado: (2022)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
por: Mariano, Filippo, et al.
Publicado: (2011)

Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Samtani, Mahesh N., et al.
Publicado: (2012)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
por: Crippa, IA, et al.
Publicado: (2015)

Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy
por: Kunka, Megan E., et al.
Publicado: (2015)

Evaluation of the registry DIALYREG for the assessment of continuous renal replacement techniques in the critically ill patient
por: González-Fernández, M., et al.
Publicado: (2023)

Fluid overload and survival in critically ill patients with acute kidney injury receiving continuous renal replacement therapy
por: Kim, Il Young, et al.
Publicado: (2017)

Beta-lactam antibiotics in continuous infusion in critically ill patients
por: Jeurissen, Axel, et al.
Publicado: (2010)

“CATCH” Study: Correct Antibiotic Therapy in Continuous Hemofiltration in the Critically Ill in Continuous Renal Replacement Therapy: A Prospective Observational Study
por: Corona, Alberto, et al.
Publicado: (2022)

Increase in Ventricle Size and the Evolution of White Matter Changes on Serial Imaging in Critically Ill Patients with COVID-19
por: Agarwal, Shashank, et al.
Publicado: (2021)

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
por: Ulldemolins, Marta, et al.
Publicado: (2014)

Vancomycin therapy in critically ill patients on continuous renal replacement therapy; are we doing enough?
por: Omrani, Ali S., et al.
Publicado: (2015)

Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study
por: Broeker, A., et al.
Publicado: (2018)

Continuous Renal Replacement Therapy in the Critically Ill Patient: From Garage Technology to Artificial Intelligence
por: Samoni, Sara, et al.
Publicado: (2021)

Body temperature and infection in critically ill patients on continuous kidney replacement therapy
por: Challener, Douglas W., et al.
Publicado: (2023)

Hemodynamic impact of the connection to continuous renal replacement therapy in critically ill children
por: Fernández, Sarah, et al.
Publicado: (2018)

Continuous renal replacement therapy in critically ill children: single-center experience
por: ERKOL TUNCER, Hatice, et al.
Publicado: (2021)

Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion
por: Ricci, Zaccaria, et al.
Publicado: (2006)

Influence of Daily Fluid Balance prior to Continuous Renal Replacement Therapy on Outcomes in Critically Ill Patients
por: Han, Min Jee, et al.
Publicado: (2016)

The Impact of Macro-and Micronutrients on Predicting Outcomes of Critically Ill Patients Requiring Continuous Renal Replacement Therapy
por: Kritmetapak, Kittrawee, et al.
Publicado: (2016)

Factors Associated with Early Mortality in Critically Ill Patients Following the Initiation of Continuous Renal Replacement Therapy
por: Kee, Youn Kyung, et al.
Publicado: (2018)

Mortality predictors in critically ill patients with acute kidney injury requiring continuous renal replacement therapy
por: Medina-Liabres, Kristianne Rachel P., et al.
Publicado: (2021)

When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injury
por: An, Jung Nam, et al.
Publicado: (2021)

1282. Ceftolozane/Tazobactam Use in Critically Ill Patients Receiving Intermittent or Continuous Renal Replacement Therapy
por: Henry, Molly, et al.
Publicado: (2021)

Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
por: He, Sha, et al.
Publicado: (2022)

Associations of continuous anionic gap detection with the mortality in critically ill patients receiving renal replacement therapy
por: Zhai, Yiling, et al.
Publicado: (2023)

Association between diuretics and successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury
por: Jeon, Junseok, et al.
Publicado: (2018)

Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2021)

Renal replacement in critically ill patients: the age factor
por: Occhigrossi, F, et al.
Publicado: (2004)

Preemptive renal replacement therapy in critically ill patients?
por: Meersch, Melanie, et al.
Publicado: (2020)

Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines?
por: Roberts, Jason A, et al.
Publicado: (2014)

The influence of hypophosphatemia on outcomes of low- and high-intensity continuous renal replacement therapy in critically ill patients with acute kidney injury
por: Kim, Soo Young, et al.
Publicado: (2017)

SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients
por: Roberts, Jason A., et al.
Publicado: (2016)

Hospital mortality and prognostic factors in critically ill patients with acute kidney injury and cancer undergoing continuous renal replacement therapy
por: Kim, Da Woon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i0761n10ungaejlv953q6rs59d